Anti IL-18 (GSK1070806) in Behcet's Disease

Clinical trial NCT03522662 · UNKNOWN

Trial details

NCT number: NCT03522662
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Behcet's Disease

Start date: 2018-08-01
Primary completion: 2020-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.